Transluminal Technologies Overview
- Year Founded
-
2008
- Status
-
Private
- Latest Deal Type
-
Later Stage VC
- Latest Deal Amount
-
$1.5M
Transluminal Technologies General Information
Description
Developer of novel, minimally invasive cardiovascular devices designed to seal the open blood vessels after surgery. The company's technology offers a vascular closure device that gives a way of reaching mechanical vascular closure which seals the arteriotomy to achieve immediate hemostasis and then absorbs over a period of days as natural healing occurs, enabling patients to properly recover after cardiovascular surgery.
Contact Information
Website
www.transluminal.netCorporate Office
- 2930 East Genesee Street
- Syracuse, NY 13224
- United States
Corporate Office
- 2930 East Genesee Street
- Syracuse, NY 13224
- United States
Transluminal Technologies Valuation & Funding
Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
---|---|---|---|---|---|---|
3. Later Stage VC | 20-Apr-2020 | $1.5M | Completed | Generating Revenue | ||
2. Seed Round | 30-Apr-2015 | Completed | Generating Revenue | |||
1. Angel (individual) | 29-Apr-2008 | $153K | $153K | Completed | Startup |
Transluminal Technologies Comparisons
Industry
Financing
Details
Transluminal Technologies Competitors (27)
One of Transluminal Technologies’s 27 competitors is NeoChord, a Venture Capital-Backed company based in Maple Grove, MN.
Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
---|---|---|---|---|---|---|
NeoChord | Venture Capital-Backed | Maple Grove, MN | ||||
ShockWave Medical | Formerly VC-backed | Santa Clara, CA | ||||
Xeltis | Venture Capital-Backed | Eindhoven, Netherlands | ||||
Cardiac Dimensions | Venture Capital-Backed | Kirkland, WA | ||||
Essential Medical | Formerly VC-backed | Exton, PA |
Transluminal Technologies Patents
Transluminal Technologies Recent Patent Activity
Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
---|---|---|---|---|---|
US-20240041472-A1 | Positive displacement closure devices and methods | Pending | 08-Aug-2022 | ||
US-20230041471-A1 | Positive displacement closure devices and methods | Pending | 06-Aug-2021 | ||
US-20200390429-A1 | Through-the-sheath trans-radial closure device, deployment apparatus, and method of deployment | Inactive | 17-Jun-2019 | ||
AU-2019309408-A1 | Suction closure devices and methods | Inactive | 26-Jul-2018 | ||
US-20200029946-A1 | Suction closure devices and methods | Inactive | 26-Jul-2018 | A61B17/1325 |
Transluminal Technologies FAQs
-
When was Transluminal Technologies founded?
Transluminal Technologies was founded in 2008.
-
Where is Transluminal Technologies headquartered?
Transluminal Technologies is headquartered in Syracuse, NY.
-
What industry is Transluminal Technologies in?
Transluminal Technologies’s primary industry is Surgical Devices.
-
Is Transluminal Technologies a private or public company?
Transluminal Technologies is a Private company.
-
What is Transluminal Technologies’s current revenue?
The current revenue for Transluminal Technologies is
. -
How much funding has Transluminal Technologies raised over time?
Transluminal Technologies has raised $3.15M.
-
Who are Transluminal Technologies’s competitors?
NeoChord, ShockWave Medical, Xeltis, Cardiac Dimensions, and Essential Medical are some of the 27 competitors of Transluminal Technologies.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read blog » -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process »